Covid 19 Vaccine Tracker

The new feature is available for Paytm users, who can scroll down to the 'Discover with Paytm' or 'Mini App store' section and find the 'Vaccine Finder' Feature.

Govt looks to speed up COVID-19 vaccine production

The government is trying multiple approaches to not only expedite vaccine production in India but also work towards quicker emergency use authorization (EUA) of foreign-made COVID vaccines.

World may see 18 percent shortfall in supply of COVID-19 vaccines in 2021: Report

Airfinity pegs the global demand for COVID-19 vaccines in 2021 at 11.5 billion doses, while the forecasted production is estimated to be 9.5 billion doses.

COVID-19 vaccination | Most beneficiaries skipped second dose, reveals government data

As of February 13, only 7,668 out of the over 1,91,000 healthcare workers who had received their first COVID-19 vaccine shot on January 16 – the first day of India’s vaccination drive - turned up for the second dose of the vaccine.

COVID-19 vaccine tracker| India may emerge as second largest vaccine maker after the US: Report

Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.

US giant Merck stops development of two COVID-19 vaccine candidates

Both V590 and V591 were generally well tolerated, but the immune responses were inferior to those seen following natural infection and those reported for other COVID-19 vaccines, said Merck

COVID-19 vaccination: Over 2.2 lakh inoculated on January 22, total beneficiaries cross 12.7 lakh

A total of 2,28,563 beneficiaries have so far been vaccinated for COVID-19 till 6 pm on the seventh day of the vaccination drive - January 22.

Over 56 million COVID-19 vaccine doses administered globally; check the country-wise tally here

The US has administered the maximum number of COVID-19 vaccine doses as on January 21, while India has covered over a million beneficiaries within the first week of its vaccination drive.

Status check on COVID-19 vaccines in pipeline for India over next six months

In the initial phase, India will inoculate about one crore healthcare workers. This will be followed by two crore frontline workers, police, armed forces, municipal workers, revenue staff and others. In the third phase, 27 crore people above 50 years of age and those with co-morbidities.

Pfizer-BioNTech vaccine appears effective against UK COVID-19 strain: Study

The research team led by BioNTech Chief Executive Officer Ugur Sahin has said the result of the study proves it is very unlikely that the UK variant viruses will be able to dodge the Pfizer COVID-19 vaccine.

Bharat Biotech not allowed to conduct simultaneous Phase I, II trials for its intranasal COVID-19 vaccine

The SEC has reportedly refused to consider Bharat Biotech’s request and said it wants the Indian vaccine maker to first conduct the phase I trials and submit the immunogenicity data before moving on to the next stage.

On Day 2 of India's COVID-19 vaccination drive, only 17,000 get their first jab: Here's why

The Health Ministry has informed that a total of 447 cases of adverse event following immunisation have been reported in India over the past two days, out of which only three required hospitalisation.

COVID-19 vaccine drive | 51 cases of minor adverse events reported in Delhi

Another person who received COVID-19 vaccine shot in Delhi on January 16 developed severe adverse event following immunization and had to be referred to the AEFI centre.

Odisha becomes first state to pause COVID-19 vaccination drive; here’s why

Sanitation worker Biranchi Naik was the first person to get vaccinated against the novel coronavirus in Odisha.

India's COVID-19 vaccination drive | 1.91 lakh inoculated on Day 1; no beneficiary hospitalised so far: Health Ministry

A total of 16,755 persons were involved in organising the coronavirus vaccination drive across 3,352 session sites.

23 senior citizens die soon after taking Pfizer COVID-19 vaccine in Norway

Both Pfizer and BioNTech are coordinating with the Norwegian drugs regulator to ascertain the cause behind the deaths of the 23 elderly persons and the former has said that the incident is not alarming and “in line with expectations."

COVID-19 vaccination | From price to availability, all your questions answered

As the COVID-19 vaccination drive begins in India, here are the answers to all your questions.

Even vaccinated people will need to take precautions against COVID-19

Both Covishield and Covaxin will be administered in two doses that are four weeks apart, indicating that it will take some time for those who have taken the shots to develop immunity.

COVID-19 vaccination | Who will not receive the vaccine, what are the side-effects?

As India is on the cusp of its nationwide COVID-19 vaccination drive, here is everything you need to know about the Centre's guidelines on vaccine contraindications, possible side-effects, and administrative precautions.

COVID-19 vaccination: Here’s which vaccine states have received and what they have planned

The Health Ministry has clarified that both the approved vaccines - Covishield and COVAXIN - will be treated at par.

COVID-19 vaccination Phase 1 begins today: Here's how India has planned the drive

The first phase of the COVID-19 vaccination should be completed within a few months. India is banking on its experience in handling large crowds during the elections.

Four more COVID-19 vaccines in pipeline in India; check details here

The Union Ministry of Health and Family Welfare said on January 12 that four more coronavirus vaccines are in the pipeline and may get the DGCI nod for emergency use authorization soon.

India's COVID-19 vaccination drive likely to last beyond one year: Health ministry

The health ministry has said no coronavirus vaccine beneficiary in India will get the choice to select a vaccine of their choice. They can get either of the two COVID-19 vaccines that have got approval in India - SII's Covishield and Bharat Biotech's Covaxin.

SII to sell Covishield for Rs 1,000 per dose in private markets: Adar Poonawalla

The first 100 million doses of Covishield were sold only to the Government of India at a special price of Rs 200 because SII wanted to support the common man, the vulnerable, the poor, and healthcare workers, said SII CEO Adar Poonawalla.

COVID-19 vaccine | Centre to purchase 4.5 crore more doses of SII's Covishied by April

The first batch of 1.1 crore doses of SII's Covishield will cost the government Rs 231 crore, while the total amount, including the 4.5 crore doses to be procured later, will cost an estimated Rs 1,176 crore at current rates.